Younis Baqi - Publications

Affiliations: 
2007-2008 Chemistry Harvard University, Cambridge, MA, United States 

51 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Fiene A, Baqi Y, Malik EM, Newton P, Li W, Lee SY, Hartland EL, Müller CE. Inhibitors for the bacterial ectonucleotidase Lp1NTPDase from Legionella pneumophila. Bioorganic & Medicinal Chemistry. PMID 27522579 DOI: 10.1016/j.bmc.2016.07.027  0.48
2016 Batalha VL, Ferreira DG, Coelho JE, Valadas JS, Gomes R, Temido-Ferreira M, Shmidt T, Baqi Y, Buée L, Müller CE, Hamdane M, Outeiro TF, Bader M, Meijsing SH, Sadri-Vakili G, et al. The caffeine-binding adenosine A2A receptor induces age-like HPA-axis dysfunction by targeting glucocorticoid receptor function. Scientific Reports. 6: 31493. PMID 27510168 DOI: 10.1038/srep31493  0.48
2015 Malik EM, Baqi Y, Müller CE. Syntheses of 2-substituted 1-amino-4-bromoanthraquinones (bromaminic acid analogues) - precursors for dyes and drugs. Beilstein Journal of Organic Chemistry. 11: 2326-33. PMID 26734081 DOI: 10.3762/bjoc.11.253  0.48
2015 Podurgiel SJ, Spencer T, Kovner R, Baqi Y, Müller CE, Correa M, Salamone JD. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism. Pharmacology, Biochemistry, and Behavior. PMID 26459156 DOI: 10.1016/j.pbb.2015.10.008  0.48
2015 Paoletta S, Sabbadin D, von Kügelgen I, Hinz S, Katritch V, Hoffmann K, Abdelrahman A, Straßburger J, Baqi Y, Zhao Q, Stevens RC, Moro S, Müller CE, Jacobson KA. Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information. Journal of Computer-Aided Molecular Design. PMID 26194851 DOI: 10.1007/s10822-015-9858-z  0.48
2015 Fuzzati-Armentero MT, Cerri S, Levandis G, Ambrosi G, Montepeloso E, Antoninetti G, Blandini F, Baqi Y, Müller CE, Volpini R, Costa G, Simola N, Pinna A. Dual target strategy: combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease. Journal of Neurochemistry. 134: 740-7. PMID 25962878 DOI: 10.1111/jnc.13162  0.48
2015 Zhang Y, Peti-Peterdi J, Müller CE, Carlson NG, Baqi Y, Strasburg DL, Heiney KM, Villanueva K, Kohan DE, Kishore BK. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus. Journal of the American Society of Nephrology : Jasn. PMID 25855780 DOI: 10.1681/ASN.2014010118  0.48
2015 Baqi Y. Ecto-nucleotidase inhibitors: recent developments in drug discovery. Mini Reviews in Medicinal Chemistry. 15: 21-33. PMID 25694081  0.48
2015 Fiene A, Baqi Y, Lecka J, Sévigny J, Müller CE. Fluorescence polarization immunoassays for monitoring nucleoside triphosphate diphosphohydrolase (NTPDase) activity. The Analyst. 140: 140-8. PMID 25372046 DOI: 10.1039/c4an01694g  0.48
2015 Yohn SE, Thompson C, Randall PA, Lee CA, Müller CE, Baqi Y, Correa M, Salamone JD. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology. 232: 1313-23. PMID 25323625 DOI: 10.1007/s00213-014-3766-0  0.48
2015 Kaster MP, Machado NJ, Silva HB, Nunes A, Ardais AP, Santana M, Baqi Y, Müller CE, Rodrigues ALS, Porciúncula LO, Chen JF, Tomé ÂR, Agostinho P, Canas PM, Cunha RA. Caffeine acts through neuronal adenosine A2A receptors to prevent mood and memory dysfunction triggered by chronic stress Proceedings of the National Academy of Sciences of the United States of America. 112: 7833-7838. DOI: 10.1073/pnas.1423088112  0.48
2014 Laurent C, Burnouf S, Ferry B, Batalha VL, Coelho JE, Baqi Y, Malik E, Mariciniak E, Parrot S, Van der Jeugd A, Faivre E, Flaten V, Ledent C, D'Hooge R, Sergeant N, et al. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy. Molecular Psychiatry. PMID 25450226 DOI: 10.1038/mp.2014.151  0.48
2014 Sassi Y, Ahles A, Truong DJ, Baqi Y, Lee SY, Husse B, Hulot JS, Foinquinos A, Thum T, Müller CE, Dendorfer A, Laggerbauer B, Engelhardt S. Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation. The Journal of Clinical Investigation. 124: 5385-97. PMID 25401477 DOI: 10.1172/JCI74349  0.48
2014 Hoffmann K, Lutz DA, Straßburger J, Baqi Y, Müller CE, von Kügelgen I. Competitive mode and site of interaction of ticagrelor at the human platelet P2Y12 -receptor. Journal of Thrombosis and Haemostasis : Jth. 12: 1898-905. PMID 25186974 DOI: 10.1111/jth.12719  0.48
2014 Horváth G, Gölöncsér F, Csölle C, Király K, Andó RD, Baranyi M, Koványi B, Máté Z, Hoffmann K, Algaier I, Baqi Y, Müller CE, Von Kügelgen I, Sperlágh B. Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents. Neurobiology of Disease. 70: 162-78. PMID 24971933 DOI: 10.1016/j.nbd.2014.06.011  0.48
2014 Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio/chow feeding choice task: reversal with antidepressant drugs. Plos One. 9: e99320. PMID 24937131 DOI: 10.1371/journal.pone.0099320  0.48
2014 Jerónimo-Santos A, Batalha VL, Müller CE, Baqi Y, Sebastião AM, Lopes LV, Diógenes MJ. Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP. Neuropharmacology. 83: 99-106. PMID 24747180 DOI: 10.1016/j.neuropharm.2014.04.006  0.48
2014 Cerri S, Levandis G, Ambrosi G, Montepeloso E, Antoninetti GF, Franco R, Lanciego JL, Baqi Y, Müller CE, Pinna A, Blandini F, Armentero MT. Neuroprotective potential of adenosine A2A and cannabinoid CB1 receptor antagonists in an animal model of Parkinson disease. Journal of Neuropathology and Experimental Neurology. 73: 414-24. PMID 24709676 DOI: 10.1097/NEN.0000000000000064  0.48
2014 Zebisch M, Baqi Y, Schäfer P, Müller CE, Sträter N. Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071. Journal of Structural Biology. 185: 336-41. PMID 24462745 DOI: 10.1016/j.jsb.2014.01.005  0.48
2014 Pinna A, Bonaventura J, Farré D, Sánchez M, Simola N, Mallol J, Lluís C, Costa G, Baqi Y, Müller CE, Cortés A, McCormick P, Canela EI, Martínez-Pinilla E, Lanciego JL, et al. L-DOPA disrupts adenosine A(2A)-cannabinoid CB(1)-dopamine D(2) receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: biochemical and behavioral studies. Experimental Neurology. 253: 180-91. PMID 24412491 DOI: 10.1016/j.expneurol.2013.12.021  0.48
2014 Nunes EJ, Randall PA, Estrada A, Epling B, Hart EE, Lee CA, Baqi Y, Müller CE, Correa M, Salamone JD. Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task. Psychopharmacology. 231: 727-36. PMID 24136220 DOI: 10.1007/s00213-013-3285-4  0.48
2014 Baqi Y, Alshaibani S, Ritter K, Abdelrahman A, Spinrath A, Kostenis E, Müller CE. Improved synthesis of 4-/6-substituted 2-carboxy-1H-indole-3-propionic acid derivatives and structure-activity relationships as GPR17 agonists Medchemcomm. 5: 86-92. DOI: 10.1039/c3md00309d  0.48
2013 Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, Müller CE, López-Cruz L, Correa M, Salamone JD. Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 19120-30. PMID 24305809 DOI: 10.1523/JNEUROSCI.2730-13.2013  0.48
2013 Silva CG, Métin C, Fazeli W, Machado NJ, Darmopil S, Launay PS, Ghestem A, Nesa MP, Bassot E, Szabó E, Baqi Y, Müller CE, Tomé AR, Ivanov A, Isbrandt D, et al. Adenosine receptor antagonists including caffeine alter fetal brain development in mice. Science Translational Medicine. 5: 197ra104. PMID 23926202 DOI: 10.1126/scitranslmed.3006258  0.48
2013 Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. Neuroscience. 250: 507-19. PMID 23867769 DOI: 10.1016/j.neuroscience.2013.07.008  0.48
2013 Collins-Praino LE, Paul NE, Ledgard F, Podurgiel SJ, Kovner R, Baqi Y, Müller CE, Senatus PB, Salamone JD. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism. The European Journal of Neuroscience. 38: 2183-91. PMID 23600953 DOI: 10.1111/ejn.12212  0.48
2013 Pardo M, López-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M. Effect of subtype-selective adenosine receptor antagonists on basal or haloperidol-regulated striatal function: studies of exploratory locomotion and c-Fos immunoreactivity in outbred and A(2A)R KO mice. Behavioural Brain Research. 247: 217-26. PMID 23557694 DOI: 10.1016/j.bbr.2013.03.035  0.48
2013 Salamone JD, Collins-Praino LE, Pardo M, Podurgiel SJ, Baqi Y, Müller CE, Schwarzschild MA, Correa M. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 972-7. PMID 22947264 DOI: 10.1016/j.euroneuro.2012.08.004  0.48
2013 Batalha VL, Pego JM, Fontinha BM, Costenla AR, Valadas JS, Baqi Y, Radjainia H, Müller CE, Sebastião AM, Lopes LV. Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation. Molecular Psychiatry. 18: 320-31. PMID 22371048 DOI: 10.1038/mp.2012.8  0.48
2012 Randall PA, Pardo M, Nunes EJ, López Cruz L, Vemuri VK, Makriyannis A, Baqi Y, Müller CE, Correa M, Salamone JD. Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. Plos One. 7: e47934. PMID 23110135 DOI: 10.1371/journal.pone.0047934  0.48
2012 Müller CE, Schiedel AC, Baqi Y. Allosteric modulators of rhodopsin-like G protein-coupled receptors: opportunities in drug development. Pharmacology & Therapeutics. 135: 292-315. PMID 22728155 DOI: 10.1016/j.pharmthera.2012.06.002  0.48
2012 Santerre JL, Nunes EJ, Kovner R, Leser CE, Randall PA, Collins-Praino LE, Lopez Cruz L, Correa M, Baqi Y, Müller CE, Salamone JD. The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. Pharmacology, Biochemistry, and Behavior. 102: 477-87. PMID 22705392 DOI: 10.1016/j.pbb.2012.06.009  0.48
2012 Baqi Y, Müller CE. Convergent synthesis of the potent P2Y receptor antagonist MG 50-3-1 based on a regioselective Ullmann coupling reaction. Molecules (Basel, Switzerland). 17: 2599-615. PMID 22391596 DOI: 10.3390/molecules17032599  0.48
2012 Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, Müller CE, Salamone JD, Correa M. Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology. 62: 2068-77. PMID 22261384 DOI: 10.1016/j.neuropharm.2011.12.033  0.48
2012 Baqi Y, Müller CE. Efficient and mild deamination procedure for 1-aminoanthraquinones yielding a diverse library of novel derivatives with potential biological activity Tetrahedron Letters. 53: 6739-6742. DOI: 10.1016/j.tetlet.2012.09.011  0.48
2012 Hildenbrand S, Baqi Y, Müller CE. Synthesis of tritium-labeled levetiracetam ((2S)-2-(2-oxopyrrolidin-1-yl) butanamide) with high specific activity Journal of Labelled Compounds and Radiopharmaceuticals. 55: 48-51. DOI: 10.1002/jlcr.1942  0.48
2011 Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD. Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease. Pharmacology, Biochemistry, and Behavior. 99: 414-22. PMID 21640750 DOI: 10.1016/j.pbb.2011.05.026  0.48
2011 Randall PA, Nunes EJ, Janniere SL, Stopper CM, Farrar AM, Sager TN, Baqi Y, Hockemeyer J, Müller CE, Salamone JD. Stimulant effects of adenosine antagonists on operant behavior: differential actions of selective A2A and A1 antagonists. Psychopharmacology. 216: 173-86. PMID 21347642 DOI: 10.1007/s00213-011-2198-3  0.48
2011 Baqi Y, Hausmann R, Rosefort C, Rettinger J, Schmalzing G, Müller CE. Discovery of potent competitive antagonists and positive modulators of the P2X2 receptor. Journal of Medicinal Chemistry. 54: 817-30. PMID 21207957 DOI: 10.1021/jm1012193  0.48
2010 Baqi Y, Müller CE. Synthesis of alkyl- and aryl-amino-substituted anthraquinone derivatives by microwave-assisted copper(0)-catalyzed Ullmann coupling reactions. Nature Protocols. 5: 945-53. PMID 20431540 DOI: 10.1038/nprot.2010.63  0.48
2010 Baqi Y, Lee SY, Iqbal J, Ripphausen P, Lehr A, Scheiff AB, Zimmermann H, Bajorath J, Müller CE. Development of potent and selective inhibitors of ecto-5'-nucleotidase based on an anthraquinone scaffold. Journal of Medicinal Chemistry. 53: 2076-86. PMID 20146483 DOI: 10.1021/jm901851t  0.48
2009 Hoffmann K, Baqi Y, Morena MS, Glänzel M, Müller CE, von Kügelgen I. Interaction of new, very potent non-nucleotide antagonists with Arg256 of the human platelet P2Y12 receptor. The Journal of Pharmacology and Experimental Therapeutics. 331: 648-55. PMID 19690189 DOI: 10.1124/jpet.109.156687  0.48
2009 Baqi Y, Atzler K, Köse M, Glänzel M, Müller CE. High-affinity, non-nucleotide-derived competitive antagonists of platelet P2Y12 receptors. Journal of Medicinal Chemistry. 52: 3784-93. PMID 19463000 DOI: 10.1021/jm9003297  0.48
2009 Baqi Y, Giroux S, Corey EJ. A study of the epoxidation of cycloolefins by the t-BuOH copper-permanganate system. Organic Letters. 11: 959-61. PMID 19182889 DOI: 10.1021/ol802923n  0.48
2009 Baqi Y, Weyler S, Iqbal J, Zimmermann H, Müller CE. Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases). Purinergic Signalling. 5: 91-106. PMID 18528783 DOI: 10.1007/s11302-008-9103-5  0.48
2008 Weyler S, Baqi Y, Hillmann P, Kaulich M, Hunder AM, Müller IA, Müller CE. Combinatorial synthesis of anilinoanthraquinone derivatives and evaluation as non-nucleotide-derived P2Y2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18: 223-7. PMID 18006312 DOI: 10.1016/j.bmcl.2007.10.082  0.48
2007 Baqi Y, Müller CE. Catalyst-free microwave-assisted amination of 2-chloro-5-nitrobenzoic acid. The Journal of Organic Chemistry. 72: 5908-11. PMID 17585825 DOI: 10.1021/jo070731i  0.48
2007 Baqi Y, Müller CE. Rapid and efficient microwave-assisted copper(0)-catalyzed ullmann coupling reaction: general access to anilinoanthraquinone derivatives. Organic Letters. 9: 1271-4. PMID 17348665 DOI: 10.1021/ol070102v  0.48
2006 Müller CE, Iqbal J, Baqi Y, Zimmermann H, Röllich A, Stephan H. Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors. Bioorganic & Medicinal Chemistry Letters. 16: 5943-7. PMID 16997558 DOI: 10.1016/j.bmcl.2006.09.003  0.48
2006 Abdel-Jalil RJ, Voelter W, Maichle-Mössmer C, Baqi Y, Machulla HJ. Crystal structure of 2-(3-acetyl-1-(4-bromophenyl)-5-((R)-4-chlorophenyl)- 1,2,4-triazolo-4-yl)-2-deoxy-1,3,4,6-tetraacetyl-β-D-glucose, C 30H31BrClN3O10 Zeitschrift Fur Kristallographie - New Crystal Structures. 221: 463-464. DOI: 10.1524/ncrs.2006.0156  0.48
2006 Al-Noaimi MZ, Abdel-Jalil RJ, El-Abadelah MM, Haddad SF, Baqi YNH, Voelter W. Metal-assisted oxidative cyclization of arylamidrazones I. Synthesis of 3-acetyl-1,4-dihydro-1-phenyl-1,2,4-benzotriazine Monatshefte Fur Chemie. 137: 745-750. DOI: 10.1007/s00706-006-0465-5  0.48
Show low-probability matches.